Company intelligence / Profile preview

Above and Beyond

Atlanta, Georgia, United States

Ownership: Private
Development stage: Other

Overview

Above and Beyond Concierge Therapeutics is a private biotechnology company focused on precision medicine for nervous system disorders. The company describes its work as combining disease characterization, personalized diagnostics, AI-driven drug discovery, and therapeutic development. Its disclosed efforts include the ALS.AI drug discovery platform and a neuromuscular restoration program aimed at neurodegenerative disease and nerve injury. Publicly available information suggests the company is at an early, preclinical stage with a small team and no clearly disclosed clinical-stage assets.

Therapeutic areas: Neurology
Modalities: Gene therapySmall moleculeStem cell therapyDevice
Industry: Biotech

Beyond the preview

Go deeper on Above and Beyond.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Above and Beyond.

Explore the full profile